Cercar

04/07/2021 Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2
Puig, L, Wu, JJ, Gooderham, MJ, You, Y, Shen, YK, Randazzo, B, Kerdel, F. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2. JOURNAL OF DERMATOLOGICAL TREATMENT. 2021; 32(5)DOI:10.1080/09546634.2019.1679336. PMID:31613178. IF:3.230(Q2/4D).
01/10/2022 MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin
Fernandez-Figueras, MT, Carrato, C, Saenz-Sarda, X, Musulen, E, Fuente, MJ, Puig, L. MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin. ARCHIVES OF DERMATOLOGICAL RESEARCH. 2022; 314(8)DOI:10.1007/s00403-021-02288-x. PMID:34647185. IF:3.000(Q2/4D).
01/08/2022 Multicentric Study on High-Frequency Ultrasound Characterization of Calcium Deposits in Dermal and Subcutaneous Calciphylaxis and Calcinosis
Gamissans, M, Giavedoni, P, Roe, E, Sanchez, J, Quintana-Codina, M, Garbayo-Salmons, P, Vidal, D, Riera-Marti, N, Lopez-Llunell, C, Romani, J, Wortsman, X. Multicentric Study on High-Frequency Ultrasound Characterization of Calcium Deposits in Dermal and Subcutaneous Calciphylaxis and Calcinosis. JOURNAL OF ULTRASOUND IN MEDICINE. 2022; 41(8)DOI:10.1002/jum.15878. PMID:34755910. IF:2.300(Q2/5D).
01/05/2022 Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain): Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers
Fernandez-Arevalo, A, Ballart, C, Munoz-Basagoiti, J, Basarte, L, Lobato, G, Arnau, A, Abras, A, Tebar, S, Llovet, T, Lami, P, Pratlong, F, Alsina, M, Roe, E, Puig, L, Munoz, C, Gallego, M. Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain): Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers. Transboundary and Emerging Diseases. 2022; 69(3)DOI:10.1111/tbed.14107. PMID:33864706. IF:4.300(Q1/1D).
01/03/2022 Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS
Ruiz-Salas, V, Sanmartin-Jimenez, O, Garces, JR, Vilarrasa, E, Minano-Medrano, R, Escutia-Munoz, B, Florez-Menendez, A, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, J, Allende-Markixana, I, Bracamonte, BG, de la Cueva-dobao, P, Ciudad, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Sanchez-Sambucety, P, Estebaranz, JL, Botella-Estrada, R, Gonzalez-Sixto, B, Martorell, A, Morales-Gordillo, V, Toll-Abello, A, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I. Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS. DERMATOLOGY. 2022; 238(2)DOI:10.1159/000517010. PMID:34380138. IF:3.400(Q2/3D).
01/01/2022 Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
Lebwohl, M, Langley, RG, Paul, C, Puig, L, Reich, K, van de Kerkhof, P, Wu, HL, Richter, S, Jardon, S, Gisondi, P. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey. Dermatology and Therapy. 2022; 12(1)DOI:10.1007/s13555-021-00635-4. PMID:34704231. IF:3.400(Q2/3D).
01/01/2022 Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases
Catala, A, Munoz-Santos, C, Galvan-Casas, C, Riesco, MR, Nebreda, DR, Sola-Truyols, A, Giavedoni, P, Llamas-Velasco, M, Gonzalez-Cruz, C, Cubiro, X, Ruiz-Villaverde, R, Gomez-Armayones, S, Mateo, MPG, Pesque, D, Marcantonio, O, Fernandez-Nieto, D, Romani, J, Pena, NI, Gonzalez, LC, Tercedor-Sanchez, J, Carretero, G, Masat-Tico, T, Rodriguez-Jimenez, P, Gimenez-Arnau, AM, Utrera-Busquets, M, Laguna, EV, Menendez, AGA, Lasser, ES, Iglesias-Sancho, M, Naranjo, LA, Hiltun, I, Marco, EC, Olabarrieta, IP, Escobedo, SM, Garcia-Navarro, X, Gutierrez, MJC, Baeza-Hernandez, G, Camps, LB, Toledo-Pastrana, T, Guilabert, A. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. BRITISH JOURNAL OF DERMATOLOGY. 2022; 186(1)DOI:10.1111/bjd.20639. PMID:34254291. IF:10.300(Q1/1D).
01/01/2022 Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)
Oro-Ayude, M, Gonzalez-Sixto, B, Sanmartin-Jimenez, O, Garces, JR, Rodriguez-Prieto, MA, Ruiz-Salas, V, de Eusebio-Murillo, E, Minano-Medrano, R, Escutia-Munoz, B, Cortizas, CF, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, Garcia-Bracamonte, B, de la Cueva-dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Cano-Martinez, N, Vilarrasa-Rull, E, Sanchez-Sambucety, P, Lopez-Estebaranz, JL, Botella-Estrada, R, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll-Abello, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I, Florez, A. Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(1)DOI:10.1111/jdv.17597. PMID:34374137. IF:9.200(Q1/1D).
01/12/2021 Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
de Bruin-Weller, M, Merola, JF, Hong, CH, Baldrich, ES, Ettler, K, Sierka, D, Delevry, D, Chen, Z, Rossi, AB. Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective. Dermatology and Therapy. 2021; 11(6)DOI:10.1007/s13555-021-00621-w. PMID:34767181. IF:3.661(Q2/3D).
01/12/2021 Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up
Papp, KA, Lebwohl, MG, Puig, L, Ohtsuki, M, Beissert, S, Zeng, J, Rubant, S, Sinvhal, R, Zhao, Y, Soliman, AM, Alperovich, G, Leonardi, C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(6)DOI:10.1111/bjd.20595. PMID:34157132. IF:11.113(Q1/1D).
01/11/2021 Diagnostic Value of Cutaneous Ultrasound in Verrucous Venous Malformation
Amat-Samaranch, V, Morales-Munera, C, Puig, L, Roe, E. Diagnostic Value of Cutaneous Ultrasound in Verrucous Venous Malformation. Actas Dermo-Sifiliograficas. 2021; 112(10)DOI:10.1016/j.ad.2021.07.002. PMID:. IF:(Q/D).
01/11/2021 Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study"
Torres, T, Chiricozzi, A, Puig, L. Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study". AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2021; 22(6)DOI:10.1007/s40257-021-00640-5. PMID:34705165. IF:6.233(Q1/2D).
01/11/2021 Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet
Cubiro, X, Garcia-Melendo, C, Morales-Munera, CE, Roe-Crespo, E, Riera-Mestre, A, Mora-Lujan, JM, Iriarte, A, Puig, L, Baselga, E. Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet. Dermatologic Therapy. 2021; 34(6)DOI:10.1111/dth.15124. PMID:34486206. IF:3.858(Q2/3D).
01/11/2021 Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"
Mercader-Garcia, P, Pastor-Nieto, MA, Gonzalez-Perez, R, Gimenez-Arnau, AM, Ruiz-Gonzalez, I, Mora-Fernandez, V, Miquel, J, Silvestre-Salvador, JF, Sanz-Sanchez, T, Perez-Feal, P, Sanchez-Perez, J, Heras-Mendaza, F, Serra-Baldrich, E, Hervella-Garces, M, Gatica-Ortega, ME, Garcia-Doval, I, Borrego, L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". CONTACT DERMATITIS. 2021; 85(5)DOI:10.1111/cod.13941. PMID:34268785. IF:6.419(Q1/1D).
01/11/2021 An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies
Blauvelt, A, Ramharter, M, Cohen, AD, Xu, W, Patel, H, Schuster, C, Riedl, E, Puig, L. An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(11)DOI:10.1111/jdv.17554. PMID:34310771. IF:9.228(Q1/1D).
01/11/2021 Oral submucous fibrosis presenting with histopathological lichenoid changes as predominant feature: Report of five cases and review of the literature
Campos, MC, Tubau, C, Segura, S, Gonzalez-Farre, M, Iglesias-Sancho, M, Fernandez-Figueras, MT, Garcia-Muret, MP, Mozos, A. Oral submucous fibrosis presenting with histopathological lichenoid changes as predominant feature: Report of five cases and review of the literature. JOURNAL OF CUTANEOUS PATHOLOGY. 2021; 48(11)DOI:10.1111/cup.14084. PMID:34151457. IF:1.458(Q4/8D).
01/11/2021 Erythematous plaques with zosteriform distribution in a patient treated with TNF-alpha inhibitor adalimumab for psoriasis
Garcia-Melendo, C, Cubiro, X, Tubau, C, Mozos, A, Munoz, C, Puig, L. Erythematous plaques with zosteriform distribution in a patient treated with TNF-alpha inhibitor adalimumab for psoriasis. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2021; 60(11)DOI:10.1111/ijd.15710. PMID:34138480. IF:3.204(Q2/4D).
14/10/2021 Phase angle by electrical bioimpedance is a predictive factor of hospitalisation, falls and mortality in patients with cirrhosis
Roman, E, Poca, M, Amoros-Figueras, G, Rosell-Ferrer, J, Gely, C, Nieto, JC, Vidal, S, Urgell, E, Ferrero-Gregori, A, Alvarado-Tapias, E, Cuyas, B, Hernandez, E, Santesmases, R, Guarner, C, Escorsell, A, Soriano, G. Phase angle by electrical bioimpedance is a predictive factor of hospitalisation, falls and mortality in patients with cirrhosis. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-99199-8. PMID:34650096. IF:4.997(Q2/3D).
01/10/2021 Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data
Cuenca-Barrales, C, Baselga-Torres, E, del Boz-Gonzalez, J, Vicente, A, Palencia-Perez, SI, Campos-Dominguez, M, Valdivieso-Ramos, M, Martin-Santiago, A, Monserrat-Garcia, MT, Azon-Masoliver, A, Feito-Rodriguez, M, Dominguez-Cruz, JJ, Roe-Crespo, E, Salas-Marquez, C, Giacaman, A, Lorente-Lavirgen, AI, Quintana-Castanedo, L, de Vega-Martinez, M, Garcia-Doval, I, Bernabeu-Wittel, J. Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data. Actas Dermo-Sifiliograficas. 2021; 112(9)DOI:10.1016/j.ad.2021.05.007. PMID:34052200. IF:(Q/D).
01/10/2021 Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients A Delphi Consensus Statement
Massey, PR, Schmults, CD, Li, SJ, Arron, ST, Asgari, MM, Bavinck, JNB, Billingsley, E, Blalock, TW, Blasdale, K, Carroll, BT, Carucci, JA, Chong, AH, Christensen, SR, Chung, CL, DeSimone, JA, Ducroux, E, Escutia-Munoz, B, Ferrandiz-Pulido, C, Fox, MC, Genders, RE, Geusau, A, Gjersvik, P, Hanlon, AM, Harken, EOB, Hofbauer, GFL, Hopkins, RS, Leitenberger, JJ, Loss, MJ, Del Marmol, V, Mascaro, JM, Myers, SA, Nguyen, BT, Oliveira, WRP, Otley, CC, Proby, CM, Racz, E, Ruiz-Salas, V, Samie, FH, Seckin, D, Shah, SN, Shin, TM, Shumack, SP, Soon, SL, Stasko, T, Zavattaro, E, Zeitouni, NC, Zwald, FOR, Harwood, CA, Jambusaria-Pahlajani, A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients A Delphi Consensus Statement. JAMA Dermatology. 2021; 157(10)DOI:10.1001/jamadermatol.2021.3180. PMID:34468690. IF:11.816(Q1/1D).
01/10/2021 Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
Mahil, SK, Yates, M, Yiu, ZZN, Langan, SM, Tsakok, T, Dand, N, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Bachelez, H, Capon, F, Contreras, CR, de la Cruz, C, Di Meglio, P, Gisondi, P, Jullien, D, Lambert, J, Naldi, L, Norton, S, Puig, L, Spuls, P, Torres, T, Warren, RB, Waweru, H, Weinman, J, Brown, MA, Galloway, JB, Griffiths, CM, Barker, JN, Smith, CH, PsoProtect Study Grp. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17450. PMID:34145643. IF:9.228(Q1/1D).
01/10/2021 Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3
Reich, K, Hansen, JB, Puig, L, Konstantinou, MP, Warren, RB. Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17433. PMID:34076919. IF:9.228(Q1/1D).
01/10/2021 Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
Sanchez-Velazquez, A, Bauer-Alonso, A, Estrach, T, Vega-Diez, D, Garcia-Muret, P, Haya, L, Penate, Y, Acebo, E, de Misa, RF, Blanes, M, Suh-Oh, HJ, Izu, R, Silva-Diaz, E, Sarriugarte, J, Roman-Curto, C, Botella-Estrada, R, Mateu-Puchades, A, Prieto-Torres, L, Morillas, V, Morillo, M, Sanchez-Caminero, P, Calzado, L, Perez-Ferriols, A, Perez, A, Dominguez, JD, Navedo, M, Muniesa, C, Combalia, A, Arroyo-Andres, J, Descalzo, MA, Garcia-Doval, I, Ortiz-Romero, PL. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17430. PMID:34062018. IF:9.228(Q1/1D).
01/09/2021 Prepubertal retroareolar cysts
Rusinol, L, Amat-Samaranch, V, Baselga, E, Puig, L, Roe, E. Prepubertal retroareolar cysts. PEDIATRIC DERMATOLOGY. 2021; 38(5)DOI:10.1111/pde.14786. PMID:34514639. IF:1.997(Q3/7D).
01/09/2021 Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?. DRUGS IN R&D. 2021; 21(3)DOI:10.1007/s40268-021-00349-0. PMID:34106430. IF:3.203(Q3/6D).
01/09/2021 Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
Iznardo, H, Vilarrasa, E, Lopez-Ferrer, A, Puig, L. Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(3)DOI:10.1111/bjd.20416. PMID:33913516. IF:11.113(Q1/1D).
01/09/2021 Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
Julia, A, Martinez-Mateu, SH, Domenech, E, Canete, JD, Ferrandiz, C, Tornero, J, Gisbert, JP, Fernandez-Nebro, A, Dauden, E, Barreiro-de Acosta, M, Perez, C, Queiro, R, Lopez-Longo, FJ, Carazo, JLS, Mendoza, JL, Alperi, M, Montilla, C, Venegas, JJP, Munoz, F, Castaneda, S, Lasanta, ML, Marsal, S, Fonseca, E, Rodriguez, J, Carreira, P, Garcia, V, Pinto-Tasende, JA, Puig, L, Ricart, E, Blanco, F, Gratacos, J, Blanco, R, Taboada, VM, Fernandez, E, Unamuno, P, Gonzalez, I, Garcia, FG, Sanmarti, R, Gutierrez, A, Olive, A, Estebaranz, JLL, Garcia-Planella, E, Torre-Alonso, JC, Andreu, JL, Ramirez, DM, Fernandez, B, Zamorano, MAA, de la Cueva, P, Mateu, PN, Vela, P, Vanaclocha, F, Coromines, H, Munoz, S, Nolla, JM, Herrera, E, Gonzalez, C, de la Fuente, JLM, Vera, M, Erra, A, Roig, D, Zea, A, Comas, ME, Tomas, C, Zarco, P, Pego, JM, Saro, C, Gonzalez, A, Freire, M, Garcia, A, Diez, E, Salvador, G, Diaz, C, Sanchez, S, Dominguez, AW, Mosquera, JA, Ramirez, J, Almaraz, ER, Palau, N, Tortosa, R, Lopez, M, Pluma, A, Aterido, A. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021; 75(9)DOI:10.1038/s41430-021-00913-6. PMID:33893449. IF:4.884(Q2/4D).
01/08/2021 Papules and vesicles on the ears of a young boy
Rozas-Munoz, E, Lopez-Sanchez, C, Piquero-Casals, J, Roe, E, Mir-Bonafe, JF. Papules and vesicles on the ears of a young boy. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2021; 60(8)DOI:10.1111/ijd.15336. PMID:33259059. IF:3.204(Q2/4D).
01/08/2021 Dual inhibition of IL-17A and IL-17F in psoriatic disease
Iznardo, H, Puig, L. Dual inhibition of IL-17A and IL-17F in psoriatic disease. Therapeutic Advances in Chronic Disease. 2021; 12DOI:10.1177/20406223211037846. PMID:34408825. IF:4.970(Q2/3D).
01/08/2021 Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology''
Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology''. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2021.03.038. PMID:33744352. IF:15.487(Q1/1D).
01/08/2021 The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study
van Straalen, KR, Tzellos, T, Guillem, P, Benhadou, F, Cuenca-Barrales, C, Daxhelet, M, Daoud, M, Efthymiou, O, Giamarellos-Bourboulis, EJ, Jemec, GBE, Katoulis, AC, Koenig, A, Lazaridou, E, Marzano, AV, Matusiak, L, Molina-Leyva, A, Moltrasio, C, Pinter, A, Potenza, C, Romani, J, Saunte, DM, Skroza, N, Stergianou, D, Szepietowski, J, Trigoni, A, Vilarrasa, E, van der Zee, HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2020.12.089. PMID:33484766. IF:15.487(Q1/1D).
01/08/2021 Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial
Puig, L, Bakulev, AL, Kokhan, MM, Samtsov, AV, Khairutdinov, VR, Morozova, MA, Zolkin, NA, Kuryshev, IV, Petrov, AN, Artemeva, AV, Zinkina-Orikhan, AV. Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00554-4. PMID:34060012. IF:3.661(Q2/3D).
01/08/2021 Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab
Lambert, J, Hansen, JB, Sohrt, A, Puig, L. Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00545-5. PMID:33988818. IF:3.661(Q2/3D).
01/08/2021 Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
Papp, KA, Soliman, AM, Done, N, Carley, C, Wirtz, EL, Puig, L. Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00550-8. PMID:34019229. IF:3.661(Q2/3D).
01/07/2021 Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses
Garcia-Melendo, C, Cubiro, X, Puig, L. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses. Actas Dermo-Sifiliograficas. 2021; 112(7)DOI:10.1016/j.ad.2020.12.006. PMID:34030992. IF:(Q/D).
01/07/2021 From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Vidal, S, Puig, L, Carrascosa-Carrillo, JM, Gonzalez-Cantero, A, Ruiz-Carrascosa, JC, Velasco-Pastor, AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(13)DOI:10.3390/ijms22136740. PMID:34201664. IF:6.208(Q1/3D).
01/07/2021 A case report of PHF6 mosaicism: Beyond the classic Borjeson-Forssman-Lehmann syndrome
Garcia-Melendo, C, Roe, E, Rodriguez-Santiago, B, Amat-Samaranch, V, Cubiro, X, Puig, L, Boronat, S. A case report of PHF6 mosaicism: Beyond the classic Borjeson-Forssman-Lehmann syndrome. PEDIATRIC DERMATOLOGY. 2021; 38(4)DOI:10.1111/pde.14636. PMID:34041787. IF:1.997(Q3/7D).
01/10/2022 Retiform purpura in an 80-year-old woman
Carmona-Rocha, E, Iznardo, H, Puig, L. Retiform purpura in an 80-year-old woman. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2022; 61(10)DOI:10.1111/ijd.16120. PMID:35106756. IF:3.600(Q1/3D).
01/07/2022 Prevalence of most common skin diseases in Europe: a population-based study
Richard, MA, Paul, C, Nijsten, T, Gisondi, P, Salavastru, C, Taieb, C, Trakatelli, M, Puig, L, Stratigos, A, EADV Burden Skin Dis Project Team. Prevalence of most common skin diseases in Europe: a population-based study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(7)DOI:10.1111/jdv.18050. PMID:35274366. IF:9.200(Q1/1D).
19/05/2022 Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis
Lebwohl, M, Soliman, AM, Yang, HB, Wang, J, Freimark, J, Puig, L. Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(4)DOI:10.1080/09546634.2021.1919287. PMID:33899655. IF:2.900(Q2/4D).